Alkermes (ALKS) stock Forecast for 2021 – 2025

Alkermes (ALKS) stock Forecast for 2022 – 2026

Last update: 05-28-2022, 12:33

Sector: Healthcare

The share price of Alkermes plc (ALKS) now

What analysts predict:: $31.75

52-week high/low: $33 / $21.24

50/200 Day Moving Average: $27.84 / $26.99

This figure corresponds to the average price over the previous 50/200 days. For Alkermes stocks, the 50-day moving average is the support level today.

For Alkermes stocks, the 200-day moving average is the support level today.

Are you interested in Alkermes plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alkermes stock price in 2022, 2023, 2024, 2025, 2026. How much will one Alkermes share be worth in 2022 - 2026?

When should I take profit in Alkermes stock? When should I record a loss on Alkermes stock? What are analysts' forecasts for Alkermes stock? What is the future of Alkermes stock?

We forecast Alkermes stock performance using neural networks based on historical data on Alkermes stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alkermes stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alkermes shares. This happens once a day.




Historical and forecast chart of Alkermes stock

The chart below shows the historical price of Alkermes stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alkermes stock price can be found in the table below.

Long-term forecasts by years.

Alkermes daily forecast for a month

Date Target Pes. Opt. Vol., %
May 30 31.45 30.67 32.11 4.69
May 31 31.11 30.52 31.68 3.82
Jun 01 31.04 30.63 31.35 2.37
Jun 02 30.49 30.05 31.19 3.80
Jun 03 30.17 29.50 30.74 4.22
Jun 04 30.08 29.56 30.37 2.74
Jun 05 29.87 29.21 30.13 3.17
Jun 06 29.92 29.70 30.39 2.32
Jun 07 29.35 28.73 29.80 3.73
Jun 08 29.31 28.61 29.93 4.62
Jun 09 29.42 28.86 29.93 3.72
Jun 10 29.26 28.65 29.47 2.88
Jun 11 29.14 28.55 29.48 3.27
Jun 12 28.69 28.49 28.95 1.61
Jun 13 28.55 28.13 29.08 3.38
Jun 14 28.53 28.14 28.79 2.34
Jun 15 28.30 27.85 28.63 2.80
Jun 16 28.26 27.81 28.75 3.38
Jun 17 28.16 27.55 28.71 4.19
Jun 18 28.17 27.93 28.45 1.87
Jun 19 27.89 27.65 28.47 2.94
Jun 20 27.05 26.68 27.25 2.14
Jun 21 27.12 26.80 27.51 2.62
Jun 22 27.26 27.09 27.46 1.35
Jun 23 27.94 27.66 28.57 3.30
Jun 24 28.55 28.27 28.81 1.91
Jun 25 28.30 27.78 28.94 4.17
Jun 26 28.66 28.15 29.28 4.01
Jun 27 28.95 28.35 29.52 4.12
Jun 28 28.62 28.07 29.16 3.88

Alkermes Daily Price Targets


Alkermes Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $31.45. Positive dynamics for Alkermes shares will prevail with possible volatility of 4.483%.

Pessimistic target level: 30.67

Optimistic target level: 32.11


Alkermes Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $31.11. Negative dynamics for Alkermes shares will prevail with possible volatility of 3.677%.

Pessimistic target level: 30.52

Optimistic target level: 31.68


Alkermes Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $31.04. Negative dynamics for Alkermes shares will prevail with possible volatility of 2.313%.

Pessimistic target level: 30.63

Optimistic target level: 31.35


Alkermes Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $30.49. Negative dynamics for Alkermes shares will prevail with possible volatility of 3.660%.

Pessimistic target level: 30.05

Optimistic target level: 31.19


Alkermes Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $30.17. Negative dynamics for Alkermes shares will prevail with possible volatility of 4.051%.

Pessimistic target level: 29.50

Optimistic target level: 30.74


Alkermes Stock Forecast 06-04-2022.

Forecast target price for 06-04-2022: $30.08. Negative dynamics for Alkermes shares will prevail with possible volatility of 2.662%.

Pessimistic target level: 29.56

Optimistic target level: 30.37


ALKS (ALKS) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 30.10 28.93 31.53 8.28
Jul. 32.25 29.62 34.28 13.59
Aug. 31.59 28.32 33.31 14.99
Sep. 29.61 26.69 31.97 16.53
Oct. 31.27 29.78 35.04 15.02
Nov. 32.60 28.22 34.59 18.42
Dec. 35.64 31.40 39.22 19.93

Alkermes forecast for this year


Alkermes Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $30.102. Pessimistic: $28.93. Optimistic: $31.53


Alkermes Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $32.2513. Pessimistic: $29.62. Optimistic: $34.28


Alkermes Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $31.5934. Pessimistic: $28.32. Optimistic: $33.31


Alkermes Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $29.6061. Pessimistic: $26.69. Optimistic: $31.97


Alkermes Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $31.267. Pessimistic: $29.78. Optimistic: $35.04


Alkermes Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $32.5959. Pessimistic: $28.22. Optimistic: $34.59


Alkermes Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $35.6436. Pessimistic: $31.40. Optimistic: $39.22




Alkermes (ALKS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 34.80 31.66 38.46 17.69
Feb 37.34 34.86 38.99 10.58
Mar 35.31 30.87 39.93 22.70
Apr 36.03 34.74 37.56 7.50
May 33.09 29.66 35.79 17.13
Jun 31.85 30.55 34.67 11.87
Jul 33.75 32.48 37.13 12.51
Aug 37.99 33.79 41.54 18.66
Sep 40.57 36.44 41.95 13.15
Oct 46.16 43.96 51.11 13.97
Nov 53.46 49.82 60.55 17.71
Dec 51.82 49.00 53.59 8.55

Alkermes (ALKS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 44.25 39.36 48.68 19.16
Feb 42.59 40.64 44.76 9.22
Mar 41.22 35.68 45.70 21.92
Apr 43.39 41.32 45.60 9.38
May 42.28 40.56 43.94 7.69
Jun 43.94 42.44 46.03 7.79
Jul 49.99 48.12 55.00 12.51
Aug 48.20 44.10 49.84 11.51
Sep 46.56 44.98 51.23 12.21
Oct 38.73 36.55 42.41 13.81
Nov 38.79 34.64 41.36 16.26
Dec 36.22 34.74 40.90 15.05



Alkermes (ALKS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 35.60 33.24 38.93 14.61
Feb 41.29 38.49 45.72 15.82
Mar 40.87 38.37 45.94 16.48
Apr 39.62 35.85 42.65 15.95
May 41.37 36.80 45.38 18.91
Jun 41.51 36.08 44.20 18.36
Jul 42.22 37.91 44.59 14.97
Aug 41.86 38.52 45.49 15.33
Sep 35.81 33.99 40.50 16.08
Oct 37.52 33.37 38.79 13.97
Nov 35.67 33.79 39.37 14.17
Dec 36.21 32.95 38.61 14.67

Alkermes (ALKS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 38.24 33.63 40.13 16.20
Feb 41.23 36.96 46.63 20.74
Mar 39.90 38.27 42.89 10.76
Apr 42.41 36.93 47.03 21.46
May 40.54 37.71 45.91 17.86
Jun 42.05 39.84 45.13 11.72
Jul 46.20 43.84 52.01 15.70
Aug 48.64 44.34 52.36 15.32
Sep 42.76 37.60 45.89 18.06
Oct 41.75 37.49 45.58 17.75
Nov 39.90 36.51 43.84 16.71
Dec 42.00 36.86 43.86 15.95

Alkermes information and performance

Alkermes plc is an Irish biopharmaceutical company that researches, develops and markets pharmaceutical products used in a variety of therapeutic areas around the world. The company’s products include drugs for the treatment of schizophrenia, schizoaffective, depressive and bipolar disorder, alcohol and opioid addiction, aids to improve walking in adults with multiple sclerosis, and a drug for the treatment of type 2 diabetes. The company serves pharmaceutical wholesalers, specialized pharmacies and distributors.

Alkermes Address

CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IE

Market Capitalization: 4 902 810 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 38 766 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -1057.29

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.381

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.108

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 588.24

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.917

Enterprise Value (EV) /Revenue

EV To EBITDA: 212.34

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 163427000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.